Related Experiment Video

Updated: Aug 17, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

Pneumococcal meningitis in infants

W Y Chan-Lui

    Brain & Development
    |January 1, 1985
    PubMed

    Insights

    Pneumococcal meningitis in Chinese infants resulted in significant mortality and high morbidity. Early signs like coma and specific cerebrospinal fluid (CSF) markers predicted fatality, while treatment challenges persisted even with sensitive antibiotics.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Neurology

    Background:

    • Pneumococcal meningitis poses a significant threat to infants, particularly in certain regions.
    • High mortality and morbidity rates necessitate a deeper understanding of risk factors and treatment outcomes.

    Purpose of the Study:

    • To review and follow up on a cohort of Chinese infants diagnosed with pneumococcal meningitis.
    • To identify factors associated with fatality and high morbidity in survivors.
    • To evaluate treatment efficacy and suggest improved management strategies.

    Main Methods:

    • A retrospective review and follow-up study of 21 Chinese infants with pneumococcal meningitis.
    • Analysis of clinical presentation, laboratory findings (including cerebrospinal fluid protein and glucose levels), and treatment data.
    • Assessment of patient outcomes, including mortality, morbidity, and neurological sequelae.

    Main Results:

    • The study observed a mortality rate of 23.8% among the infants.
    • Severe clinical signs (coma, pneumonia, disseminated intravascular coagulation) and abnormal cerebrospinal fluid (CSF) parameters (high protein, low glucose) at diagnosis were linked to fatality.
    • High morbidity in survivors was associated with neurological abnormalities, slow fever response, and incomplete normalization of CSF parameters post-treatment.

    Conclusions:

    • Pneumococcal meningitis in this cohort had severe outcomes, with specific indicators predicting fatality.
    • Even with sensitive antibiotics, high morbidity persisted, suggesting challenges in treatment and monitoring.
    • Standardized treatment and monitoring protocols are crucial, as sterile CSF does not rule out recrudescence.

    More Related Videos

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

    Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

    Published on: September 11, 2020

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...